Cell Signaling Technology

Phospho-IRS-1 (Ser1101) Antibody

#2385 · $150,366

61
Evidence Score · Well-Established
Used by 95 independent labs across 100 papers. How we score this →
100
Citing papers
18.7k
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations10MicroRNA in disease regulation10RNA modifications and cancer8Lung Cancer Research Studies8Cancer Immunotherapy and Biomarkers6Immune cells in cancer6Cancer Cells and Metastasis6Cancer-related molecular mechanisms research6

Papers citing this product

1
Hypoxic enhancement of exosome release by breast cancer cells
BMC Cancer·2012·1.1k cit.·DOI
2
CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
Journal of Clinical Investigation·2011·647 cit.·DOI
3
Astrocyte Senescence as a Component of Alzheimer’s Disease
PLoS ONE·2012·566 cit.·DOI
4
Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity
Nature Communications·2022·355 cit.·DOI
5
Proinflammatory Activation of Macrophages by Basic Calcium Phosphate Crystals via Protein Kinase C and MAP Kinase Pathways
Circulation Research·2005·353 cit.·DOI
6
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
The Journal of Experimental Medicine·2010·347 cit.·DOI
7
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Clinical Cancer Research·2016·325 cit.·DOI
8
Tumour maintenance is mediated by eNOS
Nature·2008·320 cit.·DOI
9
miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells
Stem Cells·2009·314 cit.·DOI
10
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Clinical Cancer Research·2011·301 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.